Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Treatment of autosomal dominant progressive hearing loss by in vivo delivery of genome editing agents

PROVIDER: PRJNA381788 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5419640.fastq.gz	Fastqsanger.gz
	SRR5419650.fastq.gz	Fastqsanger.gz
	SRR5419660.fastq.gz	Fastqsanger.gz
	SRR5419670.fastq.gz	Fastqsanger.gz
	SRR5419680.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 411

Similar Datasets

Project description:Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

| PRJNA994108 | ENA

DNAJC17 regulates RNA splicing in auditory hair cells and is required for hearing

Project description:RNA splicing is essential for gene regulation, but its role in maintaining cochlear hair cell function remains incompletely understood. Here, we identified a heterozygous missense variant in DNAJC17 (c.401A>C, p.E134A), which encodes a spliceosome-associated protein, that segregates with adult-onset progressive hearing loss in a multigenerational family. Hair cell-specific deletion of Dnajc17 in mice resulted in profound deafness with progressive hair cell degeneration, establishing its essential role in cochlear maintenance. Hair cells lacking DNAJC17 exhibited marked stereocilia disorganization accompanied by widespread alternative splicing defects in the cochlea. Notably, the dual-specificity protein kinase Clk1 that regulates pre-mRNA splicing showed altered exon inclusion, consistent with disruption of splicing control networks. In addition, Dnajc17 p.E134A knock in mice developed adult-onset progressive hearing loss with stereocilia and mitochondria abnormalities but preserved hair cell survival, recapitulating the human phenotype. Together, these findings identify DNAJC17 as a gene for autosomal dominant hearing loss and identify RNA splicing regulation as a key mechanism required for long-term maintenance of cochlear hair cell integrity.

2026-03-02 | GSE320419 | GEO

Pathogenic Mechanism of the PLS1 Gene Variant in Hearing Loss and Functional Validation in a Zebrafish Model

Project description:PLS1, encoding an actin-bundling protein Plastin 1, is one of the pathogenic genes responsible for autosomal dominant non-syndromic hearing loss. The cellular damage caused by mutant plastin proteins may arise from loss of function and/or dominant-negative effects. In this study, we investigated the pathogenic mechanism of PLS1 mutations by establishing both in vitro cellular models and in vivo zebrafish models. Immunoprecipitation demonstrated that the ΔExon8 mutation disrupts the intramolecular interaction between the ABD1 and ABD2 domains, while immunofluorescence colocalization revealed that the mutation alters the binding pattern of PLS1 to actin bundles and disturbs cytoskeletal organization. Through zebrafish FM1-43 uptake assays, we showed that the mutant protein impaired the functional opening and permeability of the stereociliary mechanoelectrical transduction (MET) channel. Although both PLS1-knockout zebrafish and zebrafish expressing ΔExon8-PLS1 exhibited behavioral signs of hearing impairment, defects in MET channel uptake were observed only in the mutant-expressing fish. Notably, neither PLS1 deficiency nor re-expression of human wild-type PLS1 in knockout zebrafish reproduces this MET defect. Thus, the mutation not only reduces native PLS1 function but also interferes with normal MET channel activity.

2026-05-21 | PXD076160 | Pride

Project description:Allele-specific gene editing with S. aureus Cas9-KKH prevents deafness in a model of dominant progressive hearing loss

| PRJNA541170 | ENA

EGAS00001000001-sc-20120711 - samples

Project description:Progressive Hearing Loss

| EGAD00001000197 | EGA

Deafness Gene Expression Patterns in the Mouse Cochlea Found by Microarray Analysis

Project description:This study demonstrates the baseline data of gradient gene expression in the cochlea. Especially for genes whose mutations cause autosomal dominant non syndromic hearing loss (Pou4f3, Slc17a8, Tmc1, and Crym) as well as genes important for cochlear function (Emilin-2 and Tectb), gradual expression changes help to explain the various pathological conditions.

2014-01-08 | GSE53863 | GEO

Expression data of mice cochlea treated with L-methionine and valproic acid.

Project description:Treatment of DBA/2J mice with a combination of L-methionine and valproic acid significantly attenuated progressive hearing loss. We examined gene expression in the whole cochlea of the mice. This study was aimed to detect genes of which change in expression levels were associated with attenuation of progressive hearing loss in the mice. DBA/2J mice at 4 weeks old (untreated_4-weeks, N=5), mice treated with control vehicle (0.1M sodium bicarbonate) for 8 weeks (Control_vehicle_12-weeks, N=5), and mice treated with L-methionine and valproic acid (MET_and_VA_12-weeks, N=6) were analyzed.

2015-04-15 | E-GEOD-62173 | biostudies-arrayexpress

Expression data of mice cochlea treated with L-methionine and valproic acid.

2015-04-15 | GSE62173 | GEO

Exome Resequencing of Progressive Hearing Loss

Project description:Exome resequencing of progressive hearing loss.

| EGAS00001000001 | EGA

Project description:A novel MYO6MYO6 variants identified in a Chinese family with autosomal dominant nonsyndromic hearing loss

| PRJNA1063509 | ENA